Internal Medicine, Gastroenterology · Arlington Heights, IL
NPI
1730170804
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1415 S Arlington Heights Rd
Arlington Heights, IL, 60005
Phone (847) 439-1005
Groups this clinician bills Medicare through
Medicare paid, 2024
$251K
8,944 services
Medicare patients, 2024
552
Average age 74
Drug cost, 2024
$1.5M
1,232 prescriptions
Company payments, 2025
$29K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David J Kim was code J3380 (injection, vedolizumab, intravenous, 1 mg), 6,600 times for 13 patients. In total David J Kim billed 8,944 services in 41 codes, and Medicare paid $251K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 6,600 | 13 | $17.43 | $115K |
| 99214 Office E&M - Established | Office | 308 | 219 | $95.52 | $29K |
| 45380 Lower GI Endoscopy - Other | Facility | 106 | 106 | $117.14 | $12K |
| 43239 Upper GI Endoscopy | Facility | 88 | 88 | $81.13 | $7,139 |
| 45385 Colonoscopy - Lesion Removal | Facility | 77 | 76 | $220.80 | $17K |
| 76981 Ultrasound - Nonspecific | Office | 71 | 71 | $81.98 | $5,821 |
| 99204 Office E&M - New | Office | 57 | 57 | $130.83 | $7,457 |
| 99232 Hospital E&M - Subsequent | Facility | 54 | 35 | $61.02 | $3,295 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 35 | 35 | $171.32 | $5,996 |
| 99215 Office E&M - Established | Office | 33 | 28 | $142.09 | $4,689 |
| 91200 Standard X-ray | Facility | 25 | 25 | $5.03 | $126 |
| 43235 Upper GI Endoscopy | Facility | 23 | 23 | $85.19 | $1,959 |
| 96365 Intravenous Infusion, Hydration | Office | 22 | 13 | $50.99 | $1,122 |
| 99222 Hospital E&M - Initial | Facility | 15 | 15 | $101.13 | $1,517 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 14 | 14 | $176.71 | $2,474 |
By year: 2022 $267K for 9,487 services; 2023 $264K for 9,104 services; 2024 $251K for 8,944 services.
Medicare prescription drug claims, 2024
In 2024, the drug David J Kim prescribed most often to Medicare patients was Omeprazole, with 310 prescriptions and refills. In total David J Kim wrote 1,232 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 310 | 704 | 93 | $2,799 |
| Ursodiol Generic | 134 | 327 | 36 | $30K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 118 | 118 | 114 | $2,055 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 77 | 77 | 75 | $5,155 |
| Ocaliva Obeticholic Acid | 62 | 62 | Under 11 | $596K |
| Pantoprazole Sodium Generic | 53 | 121 | 20 | $505 |
| Vemlidy Tenofovir Alafenamide | 47 | 47 | Under 11 | $72K |
| Azathioprine Generic | 44 | 127 | 14 | $2,773 |
| Prednisone Generic | 33 | 49 | Under 11 | $251 |
| Tenofovir Disoproxil Fumarate Generic | 32 | 86 | Under 11 | $14K |
| Furosemide Generic | 26 | 50 | Under 11 | $101 |
| Linzess Linaclotide | 22 | 56 | Under 11 | $30K |
| Famotidine Generic | 18 | 40 | Under 11 | $118 |
| Epclusa Sofosbuvir/Velpatasvir | 17 | 17 | Under 11 | $410K |
| Carvedilol Generic | 16 | 42 | Under 11 | $94.39 |
Brand drugs: 296 claims; generic drugs: 936 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David J Kim $29K ($29K in general payments such as food, travel and fees) from 21 companies. The largest payer was Ipsen Biopharmaceuticals, Inc with $18K.
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc IPN.PA | 11 | $18K |
| Gilead Sciences, Inc. GILD | 17 | $3,532 |
| Madrigal Pharmaceuticals MDGL | 12 | $3,172 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 12 | $2,418 |
| Abbvie Inc. ABBV | 28 | $596 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 16 | $339 |
| Astellas Pharma US Inc 4503.T | 2 | $171 |
| Pfizer Inc. PFE | 8 | $155 |
| Mallinckrodt Hospital Products Inc. | 2 | $148 |
| Lilly USA, LLC LLY | 5 | $134 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.